
Roberto Velez
Supervisory Patent Examiner (ID: 2100, Phone: (571)272-8597 , Office: P/2662 )
| Most Active Art Unit | 2829 |
| Art Unit(s) | 2662, 3600, 2829, 2858 |
| Total Applications | 468 |
| Issued Applications | 291 |
| Pending Applications | 74 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16359299
[patent_doc_number] => 20200316050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => A TOPICAL COMPOSITION BASED ON NIACINAMIDE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 16/766834
[patent_app_country] => US
[patent_app_date] => 2018-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766834
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/766834 | A TOPICAL COMPOSITION BASED ON NIACINAMIDE DERIVATIVE | Dec 16, 2018 | Abandoned |
Array
(
[id] => 15114343
[patent_doc_number] => 20190343804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/215400
[patent_app_country] => US
[patent_app_date] => 2018-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16215400
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/215400 | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators | Dec 9, 2018 | Issued |
Array
(
[id] => 16805121
[patent_doc_number] => 20210127674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => FUNGICIDAL MIXTURE COMPRISING SUBSTITUTED PYRIDINES
[patent_app_type] => utility
[patent_app_number] => 16/769404
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 3777
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769404
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/769404 | Fungicidal mixture comprising substituted pyridines | Dec 5, 2018 | Issued |
Array
(
[id] => 16341571
[patent_doc_number] => 20200306221
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => ANTITUMOR TET2 MODULATING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/768112
[patent_app_country] => US
[patent_app_date] => 2018-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16768112
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/768112 | Antitumor TET2 modulating compounds | Nov 28, 2018 | Issued |
Array
(
[id] => 15102109
[patent_doc_number] => 10472354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => 1,3-thiazol-2-yl substituted benzamides
[patent_app_type] => utility
[patent_app_number] => 16/192314
[patent_app_country] => US
[patent_app_date] => 2018-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 145722
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 291
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16192314
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/192314 | 1,3-thiazol-2-yl substituted benzamides | Nov 14, 2018 | Issued |
Array
(
[id] => 16389525
[patent_doc_number] => 20200330466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => PROCESS FOR THE PREPARATION OF RALTEGRAVIR
[patent_app_type] => utility
[patent_app_number] => 16/764026
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764026
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764026 | Process for the preparation of Raltegravir | Nov 12, 2018 | Issued |
Array
(
[id] => 14929709
[patent_doc_number] => 20190300492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/189299
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16189299
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/189299 | METHODS FOR PRODUCING VILOXAZINE SALTS AND NOVEL POLYMORPHS THEREOF | Nov 12, 2018 | Abandoned |
Array
(
[id] => 15948535
[patent_doc_number] => 10662155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Methods of preparing tecovirimat
[patent_app_type] => utility
[patent_app_number] => 16/185355
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5137
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16185355
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/185355 | Methods of preparing tecovirimat | Nov 8, 2018 | Issued |
Array
(
[id] => 16920839
[patent_doc_number] => 20210193931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/757844
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757844
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757844 | Organic electroluminescent compound, organic electroluminescent material comprising the same, and organic electroluminescent device | Nov 8, 2018 | Issued |
Array
(
[id] => 14230379
[patent_doc_number] => 20190127362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => SPIROCYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/175910
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 790
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16175910
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/175910 | Spirocyclic compounds as farnesoid X receptor modulators | Oct 30, 2018 | Issued |
Array
(
[id] => 16743264
[patent_doc_number] => 10968238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Substituted dihydropyrrolopyrazole compound
[patent_app_type] => utility
[patent_app_number] => 16/174704
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 171393
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16174704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/174704 | Substituted dihydropyrrolopyrazole compound | Oct 29, 2018 | Issued |
Array
(
[id] => 14774835
[patent_doc_number] => 20190262315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => Treatment of Breast Cancer
[patent_app_type] => utility
[patent_app_number] => 16/168896
[patent_app_country] => US
[patent_app_date] => 2018-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16168896
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/168896 | Treatment of Breast Cancer | Oct 23, 2018 | Abandoned |
Array
(
[id] => 16389524
[patent_doc_number] => 20200330465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => PROCESS FOR THE PREPARATION OF THE CRYSTALLINE FORM III OF TIPIRACIL HYDROCHLORIDE
[patent_app_type] => utility
[patent_app_number] => 16/760685
[patent_app_country] => US
[patent_app_date] => 2018-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/760685 | Process for the preparation of the crystalline form III of tipiracil hydrochloride | Oct 22, 2018 | Issued |
Array
(
[id] => 16203952
[patent_doc_number] => 20200236942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => ACTIVE COMPOUND COMBINATIONS HAVING INSECTICIDAL/ACARICIDAL PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 16/756694
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756694
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756694 | Active compound combinations having insecticidal/acaricidal properties | Oct 11, 2018 | Issued |
Array
(
[id] => 16309978
[patent_doc_number] => 20200288716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => ACTIVE COMPOUND COMBINATIONS HAVING INSECTICIDAL/ACARICIDAL PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 16/756540
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756540
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756540 | Active compound combinations having insecticidal/acaricidal properties | Oct 11, 2018 | Issued |
Array
(
[id] => 16310723
[patent_doc_number] => 20200289461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => PREVENTION AND TREATMENT OF BENIGN PROSTATIC HYPERPLASIA USING A SELECTIVE INHIBITOR OF THE PRODUCTION OF REACTIVE OXYGEN SPECIES OF MITOCHONDRIAL ORIGIN
[patent_app_type] => utility
[patent_app_number] => 16/650303
[patent_app_country] => US
[patent_app_date] => 2018-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650303
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650303 | Prevention and treatment of benign prostatic hyperplasia using a selective inhibitor of the production of reactive oxygen species of mitochondrial origin | Oct 9, 2018 | Issued |
Array
(
[id] => 16735759
[patent_doc_number] => 10961396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => Methine dyes
[patent_app_type] => utility
[patent_app_number] => 16/155017
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5972
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16155017
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/155017 | Methine dyes | Oct 8, 2018 | Issued |
Array
(
[id] => 16343500
[patent_doc_number] => 20200308150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 16/650732
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13084
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650732
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650732 | Heterocyclic compound and organic light emitting device comprising same | Sep 30, 2018 | Issued |
Array
(
[id] => 17028490
[patent_doc_number] => 11090288
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Pyrazole derivatives and their uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/141092
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8408
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16141092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/141092 | Pyrazole derivatives and their uses thereof | Sep 24, 2018 | Issued |
Array
(
[id] => 17178294
[patent_doc_number] => 11155526
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Method for producing kakeromycin and derivatives thereof
[patent_app_type] => utility
[patent_app_number] => 16/138374
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8436
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16138374
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/138374 | Method for producing kakeromycin and derivatives thereof | Sep 20, 2018 | Issued |